Find the Genovate BioTech financial statements for a comprehensive overview of the company’s financial health. This summary highlights critical numbers from key financial reports, including the ...
TAIPEI, May 28, 2024 /PRNewswire/ -- Genovate Biotechnology Co., Ltd. (TPEx: 4130), a Taiwan-based specialty pharmaceutical company, today announced its plans to submit a New Drug Application (NDA) ...
Taiwan's Genovate Biotechnology has started construction on an insulin manufacturing hub in China that aims to be the top producer by investing up to $1 billion ...
CHANGZHOU, China, Sept. 25, 2015 /PRNewswire/ -- On September 22, construction of phase I of Genovate Biotechnology's Insulin Ecological Industrial Park began in Changzhou National Hi-tech District.
Drug maker Genovate Biotechnology Co (健亞生技) plans to spend NT$3 million (US$100,300) this year and next year in a project to develop a DNA vaccine to treat cancer. On top of the NT$3 million, the ...
Genovate BioTech (TWO:4130) Annual Report This summary provides an overview of the most significant critical numbers from each of the Genovate BioTech financial reports, including the Genovate ...
4726.TWO Mycenax Biotech Inc.
On September 22, construction of phase I of Genovate Biotechnology's Insulin Ecological Industrial Park began in Changzhou National Hi-tech District. Changzhou mayor Fei Gaoyun said the city and ...
Determining whether Genovate Biotechnology Co Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the ...
Copyright 2020 FactSet Research Systems Inc. All rights reserved. Source: FactSet Fundamentals Stocks: Real-time U.S. stock quotes reflect trades reported through ...
Aaaa Aaaaaaaaaa 1,057.0 +27.25% 1,345.0 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results